Related Experiment Videos
PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids
H Ikejima1, S Haranaga, H Takemura
1Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa, Florida 33612, USA.
Abstract:
Since current studies indicate the possible involvement of Chlamydia pneumoniae in the pathogenesis of multiple sclerosis (MS), demonstration of C. pneumoniae in the cerebrospinal fluid (CSF) of patients with MS is highly desirable. However, there is controversy concerning the detection of C. pneumoniae in CSFs from MS patients due to the lack of a standard protocol for extraction and detection of C. pneumoniae DNA. In this regard, we attempted to establish a highly effective extraction protocol for C. pneumoniae DNA from CSFs utilizing a commercial kit and a PCR detection method. The extraction and PCR detection protocol established in this study succeeded in detecting as few as 20 C. pneumoniae organisms in 200 microl of mock CSF. The use of this protocol to detect C. pneumoniae DNA in CSFs revealed that 68% of CSF samples obtained from patients with MS were positive (11 out of 16 samples) for chlamydia DNA. Thus, the protocol established here is sensitive enough to detect chlamydia DNA from CSFs and can be used by other laboratories for evaluation of the presence of chlamydiae in CSFs because the protocol is based on the use of a commercial kit.
Insights
A new protocol effectively detects Chlamydia pneumoniae DNA in cerebrospinal fluid (CSF). This method found the bacteria in 68% of multiple sclerosis (MS) patients, suggesting a potential link.
Area of Science:
- Neuroscience
- Microbiology
- Infectious Diseases
Background:
- Chlamydia pneumoniae is a potential factor in multiple sclerosis (MS) pathogenesis.
- Detecting C. pneumoniae in cerebrospinal fluid (CSF) of MS patients is crucial but lacks standardized methods.
- Controversy exists regarding C. pneumoniae detection in MS patient CSF due to inconsistent protocols.
Purpose of the Study:
- To establish a highly effective protocol for extracting and detecting Chlamydia pneumoniae DNA from CSF.
- To validate the sensitivity of the developed protocol for C. pneumoniae DNA detection.
Main Methods:
- Utilized a commercial kit for DNA extraction from CSF samples.
- Employed a Polymerase Chain Reaction (PCR) based method for C. pneumoniae DNA detection.
- Tested the protocol's sensitivity using mock CSF samples spiked with known C. pneumoniae quantities.
Main Results:
- The developed protocol successfully detected as few as 20 C. pneumoniae organisms in 200 microliters of mock CSF.
- The protocol identified C. pneumoniae DNA in 68% (11 out of 16) of CSF samples from MS patients.
- Demonstrated high sensitivity for detecting chlamydia DNA in CSF samples.
Conclusions:
- The established protocol is sensitive and reliable for detecting Chlamydia pneumoniae DNA in CSF.
- This standardized method can aid other laboratories in evaluating chlamydiae presence in CSF.
- Findings support further investigation into the role of C. pneumoniae in MS pathogenesis.